This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Southwest Research Institute, The University of Texas System. Active years: 2021.
Company Filing History:
1 out of 1,126 
1 out of 5,630 
Years Active: 2021
Title: Salvatore Oddo: Innovator in Pharmaceutical Technology
Introduction
Salvatore Oddo is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative treatments for age-related diseases.
Latest Patents
Salvatore Oddo holds 1 patent for his invention titled "Inhibition of Mammalian Target of Rapamycin." This patent discloses microcapsules that contain an inhibitor of the mammalian target of rapamycin (mTOR). The invention also includes pharmaceutical compositions and kits that utilize these microcapsules. Furthermore, it outlines methods for treating or preventing age-related diseases, conditions, or disorders by administering a pharmaceutically effective amount of these microcapsules.
Career Highlights
Throughout his career, Salvatore Oddo has worked with esteemed organizations such as the University of Texas System and the Southwest Research Institute. His work has focused on advancing medical technologies and improving treatment options for various health conditions.
Collaborations
Salvatore has collaborated with notable individuals in his field, including Zelton Dave Sharp and John R. Strong. These partnerships have contributed to the development and refinement of his innovative ideas.
Conclusion
Salvatore Oddo's contributions to pharmaceutical technology and his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and offers promising avenues for future research and development.